Cardiovascular magnetic resonance (CMR) imaging uniquely characterizes myocardial and microvascular injury in acute myocardial infarction (AMI), providing powerful surrogate markers of outcomes. The last 10 years have seen an exponential increase in AMI studies utilizing CMR based endpoints. This article provides a contemporary, comprehensive review of the powerful role of CMR imaging in the assessment of outcomes in AMI. The theory, assessment techniques, chronology, importance in predicting left ventricular function and remodelling, and prognostic value of each CMR surrogate marker is described in detail. Major studies illustrating the importance of the markers are summarized, providing an up to date review of the literature base in CMR imaging in AMI. Core tip: Cardiovascular magnetic resonance (CMR) imaging uniquely characterizes myocardial and microvascular injury in acute myocardial infarction (AMI). Contrast-enhanced CMR offers robust, validated and reproducible surrogate markers, providing an accurate representation of pathophysiology, assessment of myocardial function and injury, and predictive value for medium to long-term LV function, remodelling and prognosis following primary percutaneous coronary intervention for STEMI. These qualities significantly increase the statistical power of studies using CMR endpoints and has resulted in an exponential increase in AMI studies utilizing CMR based endpoints. An understanding of the role of CMR in the assessment of outcomes in AMI is of key importance not only to interventional and imaging cardiologists, but to the cardiology community as a whole. 
INTRODUCTION
Cardiovascular magnetic resonance (CMR) imaging uni quely characterises myocardial and microvascular injury in acute myocardial infarction (AMI), providing powerful surrogate markers of outcomes. The last 10 years have seen an exponential increase in studies utilising CMR based endpoints in patients with AMI undergoing primary percutaneous intervention. This article provides a contemporary, comprehensive review of the powerful role of CMR imaging in the assessment of outcomes in AMI. The theory, assessment techniques, chronology, importance in predicting left ventricular function and remodelling, and prognostic value of each CMR surrogate marker is described in detail. Major studies illustrating the importance of the markers are summarised, providing an up to date review of the literature base in CMR imaging in AMI.
MARKERS OF OUTCOMES FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN AMI
Prognostic studies using clinical outcomes, in particular mortality require large sample sizes. Surrogate biomarkers of outcome are directly measured alternative endpoints used as a substitute for biological processes and clinical outcomes [1, 2] . CMR imaging uniquely characterises myo cardial and microvascular injury in AMI due to its accuracy, reliability and validity ( Figure 1 ) [24] . This significantly increases the statistical power of studies, allowing sample size requirements to be reduced. CMR data are strong surrogate markers of outcome following primary percutaneous coronary intervention (PPCI) in acute ST segment elevation MI.
LV EJECTION FRACTION AND VOLUMES

IN AMI
Background
In the mediumterm following STEMI, LV enddiastolic volume (LVEDV) increases, LV endsystolic volume (LVESV) decreases [57] and there can be compensatory hypertrophy of remote myocardium [8, 9] in order to preserve stroke volume and ejection fraction (LVEF). Adverse remodelling results from an inability of the heart to maintain geometry post MI in the context of large infarcts and increased wall stresses [10, 11] . An increase in LVEDVI > 20% [12, 13] and increase in LVESVI > 15% [14] at followup are the most commonly used criteria for adverse remodelling.
CMR assessment of LV volumes and ejection fraction
CMR is the gold standard modality for the assessment of ventricular function and volumes. It has higher spatial resolution than singlephoton emission computed tomo graphy (SPECT) (approximately 1.8 mm × 1.8 mm × 8 mm vs 10 mm × 10 mm × 10 mm) [15] , and suffers from little subjectivity or reliance on patient body habitus [16] . Volumes and mass are assessed on analysis of a 3D cine stack of shortaxis biventricular contiguous slices. Modern cine sequences use breathhold, electrocardiographicgated, segmented steadystate free precession (SSFP) to produce high spatial resolution images with excellent myocardium blood contrast. Regional systolic function can alternatively be assessed using wall motion scoring [17] . CMR studies have demonstrated that recovery of LVEF occurs relatively early post STEMI. Ripa showed that improvement in LVEF and systolic wall thickening occurred by 1 mo, with no further change at 6 mo [5] . The majority of improvement in LVEF occurred between day 2 and 1 wk in the study by Mather [18] , with a final increase by 3 mo. Beek showed that 55% of segments with initially impaired systolic wall thickness improved at 13wk [19] . Ganame et al [20] and Dall'Armelina et al [21] however showed that LVEF underwent no significant change by 6 and 12 mo post PPCI respectively. This may be because their subjects sustained less myocardial damage, represented by relatively preserved LVEF and thus lower potential for improvement [21] . Volumetric changes occur more slowly. Ripa et al [5] showed a continued increase in LVEDV and reduction in LVESV until 6 mo. Engblom et al [7] demonstrated similar sequelae to 12mo. Ganame showed progressive significant changes in LVEDV and LVESV and resulting LV sphericity at all timepoints to 12 mo [20] . These studies have important implications for optimising timing of followup CMR studies assessing remodelling.
The degree of impairment of LVEF and changes in volume depend on a number of CMRbased markers including infarct size (IS) [22] , microvascular obstruction (MVO) [23, 24] , intramyocardial haemorrhage (IMH) [25] and myocardial salvage [noninfarcted proportion of ischaemic area at risk (AAR)] [26, 27] . Anterior STEMI results in larger IS and lower LVEF due to the greater ischaemic AAR [28] .
Prognostic importance of LVEF and volumes in AMI
Norris et al [29] and White et al [30] first illustrated the prognostic importance of LVEF (strongest independent predictor of survival at 3.5 years) and LVESV (only independent predictor of longterm mortality at 6 years) respectively, using invasive ventriculography. Burns first demonstrated the prognostic importance of LVEF and LV volumes and their strong correlation with each other, using radionucletide analysis [31] . A large evidence base has emerged for the pro gnostic impact of impaired systolic function based on reduced CMRderived LVEF (Table 1) .
In addition to LVEFbased global systolic function, Bodi demonstrated that the number of dysfunctional segments on CMR at 1wk post STEMI was an independent predictor of combined MACE at a median followup of 553 d [38] . The evidence base for the prognostic importance of LV volumes is largely historical, based on large echocardiographic and radionucleotide studies, demonstrating the negative prognostic impact of ventricular dilatation and remodelling as summarised in Table 2 . . CMR: Cardiovascular magnetic resonance; AMI: Acute myocardial infarction; LGE: Late gadolinium enhancement. El Aidi et al [32] 2014 25497 N/A Meta analysis of prognostic value of CMR surrogate markers. LVEF was only IP for MACE (HR 1.05 per -5%)
Husser et al [33] 2012 304 7 d LVEF was IP for MACE (HR 0.95 for each +1% LVEF) 140 wk Eitel et al [34] 2011 208 3 d LVEF was IP for MACE (HR 0.95 for each +1% LVEF) 18.5 mo Amabile et al [35] 2010 114 6 d LVEF was IP for MACE (HR 0.96 for each +1% LVEF) 12 mo de Waha et al [36] Hombach et al [6] 2005 110 CMR Baseline LVEDV was IP for MACE (P = 0.038) 225 d St John Sutton et al [39] 2003 512 Echo Percentage change in LV area (surrogate for LV volume) between baseline echo and follow-up at 12 mo was IP for ventricular ectopy and VT
mo
Bolognese et al [12] 2002 284 Echo Baseline LVESV was IP for cardiac death and MACE. Components of MACE higher in patients with adverse remodelling (> 20% inc. LVEDV: Mortality 14% vs 5%, MACE 18% vs 10%)
yr
Otterstad et al [40] 2001 712 Echo Increase in LVESV between acute scan at 7 d and echo at 3 mo strongest IP for MACE 24 mo St John Sutton et al [41] 1994 512 Echo LV end-diastolic area (RR 1.1) and LV end-systolic area (RR 1.1) on baseline echo, and %-change in LV area at 12 mo echo (RR 1.55) were strongest IPs for MACE
mo
White et al [30] 1987 605 LV gram LVESV of LV gram at 4 wk was strongest IP of long-term mortality (P < 0. [46, 47] . Harmonic Phase Analysis (HARP) is currently the most widely used CMR strain method [48] . Feature tracking (FT) has been introduced as an alter native method to tagging for assessing strain on CMR. FT tracks anatomical features of interest along contour lines on routinely acquired SSFP cine images analogous to echocardiographic Speckle Tracking, obviating the need for additional tagging sequences [49] . FTderived strain has been compared to tagging in acute STEMI and shown greater feasibility, accuracy and observer agreement [50] and remains an exciting prospect.
CMR LV strain as a predictor of LV function and remodelling in AMI
Strain could improve our understanding of the mechanics underlying LV dysfunction associated with prognostic CMR surrogate markers of myocardial damage in STEMI (e.g., MVO, IMH, oedema).
Systolic function is also in remote (noninfarcted) segments, and LV mechanics outside of the infarct zone are also affected during infarction and contribute to remodelling [44, 51, 52] . MVO had the highest predictive value for persistent dysfunction on circumferential strain at 7mo post STEMI and may result in systolic dysfunction due to direct mechanical effects (myocardial stiffness) [53] . Baseline segmental circumferential strain was the strongest predictor of segmental functional recovery at 3mo in a model containing infarct transmurality and MVO [54] . FT derived global circumferential strain assessed acutely post PPCI was recently shown to correlated strongly with Recently, left ventricular global performance index has been proposed as a CMR marker of cardiac performance, incorporating LVEF, LV volumes and mass. It has been assessed in one study in STEMI and correlated strongly with IS, MSI, MVO and IMH extent, and had incremental prognostic value to LVEF in predicting 12mo MACE [42] . Further work is needed to investigate its prognostic value in STEMI.
MYOCARDIAL STRAIN IN AMI
CMRmeasured myocardial strain (tissue deformity) is the gold standard noninvasive measure of systolic and diastolic myocardial function [43] . Circumferential strain (Ecc) describes shortening of fibres (contraction) in a shortaxis plane tangential to the epicardium; longitudinal strain (Ell) describes shortening in the long axis, and radial strain (Err) describes lengthening (thickening) of fibres towards the centre of the ventricle. Torsion is wringing of the ventricle caused by clockwise rotation at the base, and anticlockwise at the apex.
Strain offers greater accuracy in detecting myocardial dysfunction compared with global (LVEF) and regional (visual wallmotion scoring, segmental wall thickening) [44] measures.
CMR assessment of myocardial strain
In 1989, Axel et al [45] developed a T1 spoiled gradient echo sequence, creating "tags" formed by saturation of thin myocardial lines running in perpendicular directions in plane to form a myocardial grid. These lines act as tissue markers, tracking myocardial deformation as shown in Figure 2 . Peak systolic strain and peak diastolic strain In acute infarct, LGE results from gadolinium entering ruptured cell membranes. In chronic infarction, LGE results from increased extracellular space due to collagen deposition and prolonged washout due to reduced capillary density within myocardium [60, 63] . Gadolinium shortens T1, causing infarcted myocardium to appear bright, and normal myocardium to appears black ( Figure  4 ) [63, 64] . Normal myocardium is progressively nulled using the appropriate inversion time to provide optimal contrast between infarct and normal myocardium.
Typically, a high spatial resolution of approximately 1.4 mm × 1.6 mm × 68 mm is achieved [15] . IS is typically expressed as a percentage of total LV mass. Delineation of infarct can be performed visually (manual quantification) [6, 9, 22] , however most groups use semi automated methods to reduce observer variability. These include enhancing myocardium exceeding a pre defined signal intensity (SI) threshold, typically > 26 standard deviations above that of remote (noninfarcted) myocardium [2, 65] . Currently, the semiautomated full width at halfmaximum (FWHM) method is commonly used [6670] , defining infarct as myocardium with SI > 50% of the peak SI in the infarct core. Amado demonstrated that FWHM had the highest interobserver agreement and closest correlation with TTCstained infarct in a dog model of acute infarction (r 2 = 0.94), compared with standard acute IS on late gadolinium enhancement (LGE) imaging (r = 0.75) and final LVEF at 6 mo (r = 0.71). Global circumferential strain was a stronger predictor of functional recovery (LVEF > 50%) at 6 mo than global longitudinal strain, age, diabetes and baseline LVEF, and was of similar predictive value to acute IS [AUC 0.86 (Ecc) vs 0.92 (IS)] [55] .
Prognostic importance of LV strain in AMI
The evidence base for the prognostic importance of LV strain post STEMI is currently based on echocardiographic studies demonstrating that global longitudinal predicts medium and longterm using Speckle Tracking analysis as summarised in Table 3 .
INFARCT SIZE IN AMI
Background
The "ischaemic cascade" is the sequence of patho physiological effects developing immediately following coronary occlusion. Aerobic respiration loses efficiency resulting in cellular oedema. With increasing ischaemic time, cell membranes rupture. Following healing, necrotic cells are replaced by extracellular collagen deposition (scar). The acute and chronic phases are characterised by increased myocardial extracellular volume [6062] .
CMR assessment of IS in AMI
Gadolinium contrast agents are large extracellular [56] 2014 1048 TTE (E-prime divided by peak early diastolic strain rate) strongest IP of MACE and death 29 mo Ersbøll et al [57] 2013 849 TTE GLS was IP of MACE 30 mo Hung et al [58] 2010 610 TTE GLS and strain-rate, and GCS and strain-rate IPs for MACE in model with WMS, LVEF 25 mo Antoni et al [59] 
A B C
Khan JN et al . CMR assessment of outcomes in AMI estimate true IS. Studies of IS chronology in humans corroborate this (Table 4) . Indeed, severely dysfunctional segments with minimal myocardial salvage early post STEMI can show significant functional improvement at followup [73] . The majority of IS reduction occurs relatively early post STEMI, particularly by 1 wk. Indeed IS assessed at 1 wk has been shown to closely correlate with final IS [7, 9, 18] .
Overestimation of necrosis by
LGEderived IS early post STEMI is due to a combination of oedema, infarct resorption and partial volume effects. Oedema results in an overestimation of LGE IS due to increased extracellular water content and thus volume of distribution of contrast agent [66, 75] . Infarct resorption results from the healing process where collagenous scar tissue is produced to provide stability and tensile strength to necrotic myocardium [7, 11] . This was confirmed in a canine model where a 3.4-fold decrease in infarct volume was seen between day 3 and 8wk post infarct on ex-vivo LGE and TTCstained slices [64] . The degree of infarct resorption has been shown to be proportional to initial IS (r = 0.65) and presence of LV remodelling (r = 0.41) [10] . The greater degree of infarct resorption relative to total myocardial deviation methods [66] . This may be because FWHM is less prone to IS overestimation in the presence of oedema, and partial volume effects giving rise to intermediate signal intensities [18, 71] . Comparing techniques in STEMI patients showed that FWHM quantification had the lowest intraobserver and interobserver variability, and greatest agreement with LVEF [72] . CMR measurement of IS on LGE is well validated [63, 64] . Kim demonstrated that IS in dog myocardium on exvivo CMR corresponded closely with IS derived from tetrazolium (TTC) staining (r = 0.99) [15, 64] .
LGE has higher sensitivity for infarct detection compared with SPECT. In an experimental model of MI, CMR LGE detected 92% of all segments with subendocardial infarction (< 50% transmurality) compared with only 28% with SPECT [15] . In patients with MI, SPECT only detects approximately 50% of the infarcts seen on LGE. The superior sen sitivity is due to the increased spatial resolution and reproducibility of CMR [60] . Since gadolinium is distributed throughout the extra cellular space, gadolinium contrast agents are not specific to necrosis. Acutely, the area of LGE detects not only necrotic cells but also the increased (oedematous) interstitium surrouding viable cells, and thus can over LGE method Main findings
A B
Carrick et al [74] 2016 30 8 h → 3 d → 10 d → 7 mo 26% Automated Significant decrease d3 to d10 (20% ± 13% to 14% ± 10% LV mass).
No change at 7 mo Dall'Armelina et al [21] 2011
30 2 d → 6 mo 22% > 2SD IS reduced at times from 27% ± 15% LV mass 24 h post PPCI, to 21% ± 11% at 6 mo Mather et al [18] 2011
27% IS drop between d2 and d7 post PPCI, no change at 3 mo
Ganame et al [20] recovery in dysfunctional segments following PPCI for acute STEMI, as summarised in Table 5 .
Global function: IS is a powerful independent predictor of global LV function and adverse LV remodelling in the medium to longterm post STEMI as summarised in Table 6 .
Prognostic importance of CMR-derived IS in AMI
The goal of STEMI management is early reperfusion in order to minimise IS and thus maximise myocardial salvage [95] . There is a strong evidence base for the prognostic importance of CMRderived IS post STEMI, as summarised in Table 7 . IS strongly predicts medium to longterm clinical outcomes. mass and volume results in an inability to maintain LV geometry in light of mechanical stresses post STEMI, resulting in adverse LV remodelling and sphericity [10, 76] . Factors known to affect IS include AAR extent [7779] ; collateral flow to the AAR [79, 80] ; MVO [81] ; time to reperfusion [82] and hyperglycaemia [83] .
CMR IS as a predictor of LV function and remodelling in AMI
Segmental function: Kim illustrated in stable patients awaiting revascularisation, that LGE transmurality strongly predicted recovery of systolic function in dysfunctional segments. Only 2% of segments with > 75% transmurality improved after revascularisation [84] . Segmental extent of LGE has also been shown to negatively predict functional [91] 2012 118 > 2SD No. segments > 50% transmurality IP for LVR 6 d 6 mo Ezekowicz et al [92] 2010 64 Manual IS strongest IP of LVEF in model with MVO, troponins 7 d 3 mo Ganame et al [25] 2009 98 Manual IS strongest IP of LVR (>> MVO, AAR, Troponin-I) 2 d 6 mo Bodi et al [93] 2009 214 > 2SD Extent of transmural necrosis (no. segments > 50% TEE) strongest IP for LV recovery (+ > 5% LVEF)
d 6 mo
Wu et al [94] 2008 [28, 104] ; and (3) Hypointensity within infarct core on LGE due to absence contrast perfusion, known as "late MVO (LMVO)". LMVO occurs in upto 60% of patients on CMR within the first week post STEMI [5, 6, 18, 20] . This is the preferred method of MVO demonstration in contemporary clinical practice and research.
LMVO extent is maximal at 48 h post infarct [8, 18] , and then decreases. It exists for at least 1 wk, and for up to 1 mo [8, 18] and then resolves in the mediumterm in humans (Table 8 ). Animal models corroborate these findings [105, 106] . The extent of MVO on CMR has been shown to correlate with IS [82, 94, 107, 108] , oedema, IMH, TIMI-flow pre PCI [35, 109] and time to reperfusion [35, 82, 110] .
CMR MVO as a predictor of LV function and remodelling in AMI
LMVO is a strong independent predictor of medium term LV function and adverse remodelling (Table 9 ). It
MVO IN AMI
Background
Despite prompt IRA recanalization, perfusion of the microcirculatory bed does not always ensue. Histo pathogical studies have demonstrated that the infarct core (endocardial) perishes first as necrosis spreads transmurally towards the epicardium. This is known as the "wavefront theory" [100] . At the infarct core, necrosis occurs rapidly with myocardial and capillary endothelial cells perishing simultaneously. Capillaries can become obstructed by cellular debris, resulting in nonperfusion of the infarct core, despite IRA patency [101] . This is known as MVO and can be indicated at angiography, as "no reflow" [101] .
CMR assessment of MVO in AMI
Three CMR methods demonstrate MVO ( Figure 5 ). MVO extent is typically expressed as a percentage of LV mass: (1) Qualitative first-pass rest perfusion. A modified version involves quantification of myocardial blood flow (SI time curve) and time to 50% of maximal SI [102, 103] ; (2) Hypoperfusion on inversion recovery images between 13 A B Table 7 Cardiovascular magnetic resonance studies illustrating the prognostic importance of infarct in acute myocardial infarction
Ref.
Year n
LGE method Main findings CMR timepoint
Follow-up
Husser et al [96] 2013 250 > 2SD Extent of transmural infarction (no. of segments > 50% transmurality) only IP for MACE at 6 mo 7 d 163 wk
Izquierdo et al [97] 2013 440 > 2SD IS was IP for AACEs (arrhythmic cardiac events: Sudden death, VT, VF, ICD shock) in model including LVEF, hypertension 7 d 123 wk
Eitel et al [34] 2011 Khan JN et al . CMR assessment of outcomes in AMI cardiovascular death (HR 13.2) at 2 years independent of IS and LV volumes. The strong adverse prognostic value of LMVO may be due to its negative effects on LV function, wall thickness and stiffness, and remodelling, and subsequent risk of heart failure and arrhythmias [6, 20, 92, 111113] .
IMH IN AMI
Background
IMH is a reperfusion injury occurring when restored blood flow into damaged capillaries extravasates erythrocytes into myocardium [121, 122] . CMRderived IMH was first described in reperfused canine myocardium on ex-vivo T2weighted spinecho (T2wTSE) imaging with excellent agreement with histology (r = 0.96 for IMH extent) [123] .
CMR assessment of IMH in AMI
Paramagnetic haemoglobin breakdown products shorten T2 relaxation times [123, 124] . IMH is seen as hypointense zones within hyperintense oedematous myocardium on T2wTSE sequences. It shows good histological correlation in canine myocardium (ex-vivo MRI, r = 0.96) [123] and in an human autopsy case series (in-vivo MRI, r = 0.97) [124] .
is likely that this is because L-MVO reflects more severe microvascular and myocardial damage than EMVO [28, 36] . In most studies demonstrating the independent predictive value of LMVO on LV function and remodelling, EMVO was not a predictor [103, 111, 112] . LMVO was a predictor independent of baseline IS [6, 20, 92, 111113] . Monocyte recruitment, crucial in cellular debris removal and scar formation, is impaired in areas of LMVO in rat myocardium and may contribute to the adverse remodelling [114] .
Prognostic importance of CMR MVO in AMI
An increasing evidence base demonstrates the strong mediumterm prognostic value of LMVO following STEMI, independent of IS and LVEF [6, 36, 37, 116] (Table 10 ).
The 2 studies featuring both LMVO and EMVO showed that LMVO was a stronger prognostic indicator [36, 37] . Regenfus et al [117] demonstrated that LMVO was the strongest IP of longterm combined MACE at 6 years followup in a model including CMRassessed LVEF and IS (HR 3.9), providing incremental prognostic value over traditional CMR markers of myocardial damage. A metaanalysis [118] (8 studies, n = 1025) demonstrated that LMVO presence was the strongest independent predictor of mediumterm combined MACE (HR 3.7) and 
Follow-up
Kidambi et al [115] 2013 39 > 2SD L-MVO only IP of impaired infarct strain. Model with IS, TIMI flow, diabetes, transmurality
Wong et al [103] 2012 40 Manual L-MVO extent only IP for LVEF at 3 mo in model including E-MVO, IS and myocardial blood flow on perfusion 3 d 3 mo
Ezekowitz et al [92] 2010 64 Manual L-MVO extent was IP of LVEF in model with IS and NTproBNP
Weir et al [112] 2010 100 Manual L-MVO extent was only IP of LVR in model with TIMI post PCI, E-MVO, IS
d 6 mo
Ganame et al [25] 2009 98 Manual L-MVO extent was IP of LVR in model with IS, troponin-I, TTR
Nijveldt et al [111] 2008 60 T2wTSE was present in 33% of patients, with maximal extent at 48 h post PPCI and progressively resolution by 3 mo. Carrick et al [74] recently demonstrated that the incidence and extent of IMH on T2* increased between 8 h and 3 d post PPCI. Its extent was significantly lower at 10 d and was seen in only 13% of patients at 7 mo. The authors also found that MVO was present in all patients with IMH, and its extent peaked earlier at 8 h suggesting that IMH is an ensuing reperfusion injury in regions of MVO.
CMR IMH as a predictor of LV function and remodelling in AMI
There is a small evidence base demonstrating that IMH is a strong univariate predictor of mediumterm impaired LV function and remodelling, however multivariate analysis reveals mixed results, with some studies suggesting no incremental predictive value of IMH over MVO and IS (Table  11) .
IMH occurs exclusively in areas of LMVO (r 2 for co localisation approximately 0.9) (Figure 6 ) [25, 33, 125, 126] . Newer sequences based on direct quantification of T2 and T2* [74, 126129] allow IMH to be quantified without the limitations of T2wTSE imaging. Initial studies have been promising and shown that these sequences are reproducible and appear more sensitive and accurate than T2wTSE for IMH detection [126, 130, 131] . O'Regan et al [126] showed that T2* had 100% sensitivity for IMH detection compared to 90% for T2wTSE, where the "gold standard" was colocalisation with LMVO. In canines, T2* in haemorrhagic infarcts closely correlates with iron levels on spectrometry, and T2*detected IMH colocalises with iron deposition on Perl's staining [132] and extravasated erythrocytes on HaematoxylinEosin staining [128] . In pigs, regions of IMH on T2* imaging showed vessel degeneration and iron deposition [8] .
There is a paucity of data on temporal changes in CMRdetected IMH. Mather et al [18] showed that IMH on 
Follow-up
Regenfus et al [117] 2015 249 Manual L-MVO extent strongest IP for MACE in model including IS, LVEF, TIMI pre and post PPCI and no. diseased vessels
d 72 mo
Eitel et al [119] 2014 [36] 2010 438 Manual Presence and extent of L-MVO were strongest IPs for MACE and mortality in models with IS, LVEF, ST-res, TIMI-flow post PCI. E-MVO was not an IP
d 19 mo
Cochet et al [37] 2009 184 Manual L-MVO strongest IP for MACE, in models including GRACE score, IS, LVEF.
L-MVO stronger IP than E-MVO (OR 8.7 vs 2.5) "3-7 d" 12 mo
Bruder et al [116] regional water content [135] . T2wTSE sequences illustrate oedema as hyperintensity [134] and are currently the main stay of CMR oedema imaging. Most commonly used is the blackblood T2weighted shorttau inversionrecovery sequence (T2wSTIR). This uses two initial inversion pulses to null moving blood. This is followed by a third inversion pulse, which nulls tissues with short T1 times (fat) to provide high contrast between blood (nulled) and myocardium [134, 136] . T2w imaging of myocardial oedema is wellvalidated in animal studies assessing myocardial water volume on histological assessment [137] and fluo rescent microspheres [77] . T2w oedema assessment is well validated with SPECT [138140] and angiographic markers of AAR (BARI [141] , APPROACHp [142] scoring). AAR on T2w can be assessed accurately for upto 1wk postPPCI unlike SPECT, which requires radionucleotide administration during coronary occlusion and has higher spatial resolution and thus ability to detect subendocardial injury [138] . However T2wTSE imaging has inherent disadvantages that can compromise image quality and oedema de tection. Upto 30% of datasets are nonanalysable in studies [24, 143, 144] . New T2w sequences have been studied, with encouraging results (Figure 7) .
The aim of prompt reperfusion is to limit IS by mini mizing the conversion of reversibly injured myocardial cells (AAR) into necrotic, infarcted tissue (IS) [95, 156] . Anterior STEMI typically results in larger IS due to the larger coronary bed supplied by the left anterior descending artery [14, 80, 82] . Hence a more accurate assessment of revascularisation strategies can be provided by adjusting IS for the AAR. The resulting myocardial salvage index (MSI) defines the proportion of reversibly injured tissue (AAR) that does not progress to infarction (IS, Equation 1, Figure 8 ). MSI is expressed as percentage of the initial AAR [0% is no salvage, 100% is complete salvage (aborted
Prognostic importance of CMR IMH in AMI
Multivariate analyses including IMH as a prognostic indicator also show mixed results. Amabile et al [133] demonstrated that IMH on T2wTSE at 4 d post STEMI was the strongest independent predictor of MACE at 1year (HR 2.8) in a model including LVEF, STresolution and LMVO. Husser et al [33] showed that only LVEF and IMH extent on T2wTSE independently predicted MACE at 140 wk followup in a model containing LV volumes, AAR, IS and LMVO. However IMH and MVO extent showed strong correlation (r = 0.95) and adding T2w imaging to a model containing LGE and cine imaging did not improve the predictive power for MACE, supporting a strong concordance of IMH and MVO. Eitel et al [125] demonstrated that IMH presence on T2wTSE and LVEF < 53% were the only CMR independent predictors of MACE at 6 mo in a model with lone MVO. Carrick et al [74] recently demonstrated that IMH on T2* mapping was the strongest independent predictor of cardiac death and heart failure hospitalisation at 830 d followup. In their multivariate model, LMVO was not a predictor suggesting that IMH reflects extreme microvascular injury.
ISCHAEMIC AAR AND MYOCARDIAL
SALVAGE IN AMI
Background
Oedema is seen in acute cardiac inflammation. In STEMI, it signifies reversible myocardial injury in the ischaemic cascade. The area of oedematous myocardium defines the ischaemic AAR supplied by the occluded IRA [61, 134] .
CMR assessment of AAR and MSI in AMI
The T2 (transverse) relaxation time is increased by [74] 2016 245 T2* IMH strongest IP for LVR. IMH associated with lower LVEF and greater volumes 3 d 7 mo
Kidambi et al [115] 2013 39 T2w-TSE and T2* IMH associated with attenuation of follow-up infarct strain 3 d 3 mo
Husser et al [33] 2012 304 T2w-TSE IMH strongest IP for LVR in model with LVEF, IS, LV vol, L-MVO 6 d 189 d
Mather et al [131] 2011 48 T2w-TSE and T2* IMH strongest IP of LVR in model with IS, LVEF, LVESV, E-MVO, MSI 2 d 3 mo
Beek et al [24] 2010 45 T2w-TSE IMH was a univariate predictor of LVEF. However no prognostic significance beyond baseline LVEF and MVO in predicting final LVEF
d 4 mo
Bekkers et al [121] 2010 90 T2w-TSE Acute MSI and LVEF increase at follow-up lowest if IMH present. But IMH no prognostic significance beyond MVO in predicting LVEF
d 103 d
O'Regan et al [126] 2010 50 T2* IMH presence univariate predictor of LVEF and LV volumes. However only IS independently predicted LVEF 3 d N/A Ganame et al [25] 2009 98 
CMR MSI as a predictor of LV function and remodelling in AMI
Myocardial salvage is a strong univariate predictor of mediumterm LV function [14, 166, 167] and adverse LV re modelling post STEMI [14, 27, 91, 161] . Multivariate analysis demonstrates mixed results. MSI independently predicted LV remodelling in the work of Mather [131] (Table 13 ).
However MSI was not a predictor once IS was added into multivariate models in studies by Monmeneu [91] and Masci [14] . This, in conjunction with the correlation between MSI and IS, and AAR and IS [26] questions whether MSI and IS are truly independent of each other in predicting LV remodelling and prognosis post STEMI. It could be argued that since MSI adjusts IS for the extent of AAR, it may have less inherent variability than IS. Since up to 30% of AAR datasets have been deemed nondiagnostic in previous studies [24, 143, 144] , this may impact on the robustness of MSI quantification whereas IS datasets are exceptionally rarely excluded based on image quality. It is not clear currently whether IS or MSI is the better measure of revascularisation success post PPCI.
Prognostic importance of CMR MSI in AMI
Historically, the prognostic value of MSI was demonstrated using SPECT. Ndrepapa first showed that MSI was the strongest independent predictor of 6mo mortality [168] . MSI was an independent prognostic indicator in the medium term post STEMI in two studies. Although both studies were from the same patient cohort, they have both been STEMI)] [157] .
Equation 1: Myocardial salvage index (MSI, %) = 100 × [(AARIS)/(AAR)].
Desch showed excellent intraobserver and inter observer agreement for MSI assessment using T2wSTIR and LGE (coefficients of variation approximately 5.0%) and excellent testretest reproducibility in a study of 20 acute STEMI patients [158] . Other determinants of AAR include TTR [91, 130, 159162] , extent of collateralised IRA territory flow [5, 80, 159, 163] , TIMI flow pre PPCI, LAD IRA and diabetes [91] . Studies of the chronology of oedema suggest that it occurs very early in the ischaemic cascade. AbdelAty confirmed the presence of transmural oedema in canines on in-vivo T2w imaging at 28 min post LAD occlusion at which point LGE and troponin release were absent, indicating reversible injury [164] . FernándezJiménez et al [165] however recently demonstrated a bimodal pattern of AAR extent in pigs with T2mapping CMR and histological water quantification. They showed peak values at 2 h thought to be a direct result of reperfusion, followed by a return to baseline at 2 d and then progressive increase towards peak values at 7 d, with the latter peak felt due to water replacement of cleared cellular debris. Studies of temporal changes in AAR and MSI in humans are summarised in Table 12 . Correct timing of oedema imaging is crucial in accurate calculation of AAR and MSI.
The nearresolution of oedema by 6 mo [5, 18, 21, 91, 138] allows distinction between acute and chronic infarcts when combined with LGE imaging.
Disadvantages of T2w TSE for oedema assessment Relatively long breath-hold Artefacts from poor breathholding and arrhythmias Low contrast to noise ratio as relatively small changes in T2 with oedema (CNR 2.9 STIR AAR v CNR 19 LGE IS) "Slow-flow" artefact with potential for false positives in areas of hypokinesia Signal intensity inhomogeneities from phased-array coils Signal loss at inferolateral wall due to cardiac motion and unwanted nulling of myocardium (false negative) Alternative sequences studied in small series (1) Non-contrast T1w as oedema increases T1 too (distinguishes acute from chronic MI well) (2) Bright blood TSE (double inversion; less motion artefact than STIR, better accuracy); recently single-shot version of sequence showed higher CNR, intra-observer agreement and accuracy (AUC 0.86) than STIR for AAR (3) SSFP (good image quality, correlates with STIR, short scan as SSFP used for AAR and LV function) (4) Hybrid of SSFP/TSE ("ACUT2E": Better CNR than STIR; high CNR of SSFP and oedema-specific T2w) (5) T2 quantification and production of T2 maps (as higher T2 in oedema; accurately defined oedema; faster acquisition than STIR; more robust, with on effect of slow-flow, through-plane motion or coil related SI differences); higher intraobserver agreement (6) Endocardial surface length of infarction (ESL): Proposes that endocardial circumferential length of infarct occurs early and correlates with AAR as infarct extends transmurally (surrogate for AAR); underestimates AAR compared with STIR (7) DWI: DWI is T2w and sensitive to water content. Was not affected by coil signal intensity inhomogeneities, slow-flow artefact or motion artefact, with higher sensitivity 83% vs 61% STIR Figure 7 Alternative sequences to dark-blood T2-weighted turbo spin-echo for visualising oedema. Left: Inherent disadvantages of T2w-TSE [134, [144] [145] [146] [147] ; Right: Sequences compared with T2w-TSE: (1) [145] , (2) [141, 142, 144, 148] , (3) [149, 150] , (4) [144] , (5) [151, 152] , (6) [153, 154] , (7) [155] . T2w-TSE: T2-weighted turbo spin-echo; DWI: Diffusionweighted imaging; AAR: Area at risk.
sequences. This can lead to subjectivity and dependence upon optimal nulling of normal myocardium and thus potential for error. In addition, commonly used T2wTSE sequences suffer from nondiagnostic image quality in upto 30% of patients [24, 143, 144] . T1, T2 and T2* quantification present an exciting and complementary approach to LGE and T2w imaging. Developed by Messroghli et al [169] in 2003, their use in MI research has accelerated over the last 5 years. They allow not only the location and extent of infarction, oedema, MVO and IMH to be determined from subsequent parametric myocardial maps, but also the severity of these pathologies to be assessed through the magnitude included in Table 14 due to their differing primary findings.
T1, T2 AND T2* QUANTIFICATION AND MAPPING IN AMI
The current mainstay of LGE and T2w techniques for the detection of infarct and oedema rely on semiquantitative thresholdbased quantification methods using arbitrary SI cutoffs compared to userdefined regions of inter est, automated algorithms or are based on manual planimetry. There is currently no consensus on the optimal quantification method for IS or AAR using these Table 12 Temporal changes in cardiovascular magnetic resonance-derived area at risk and myocardial salvage index in acute myocardial infarction Ref.
A B C D E
Year n CMR timepoints post STEMI AAR, IS method
Main findings
Mather et al [18] 2011 48 2 d → 1 wk → 30 d → 3 mo
LGE AAR reduction at successive timepoints, 1-3 mo (-75%). No change MSI at d2 or 1 wk as IS and AAR decreased proportionally Dall'Armelina et al [21] 2011 30 2 d → 1 wk → 2 wk → 6 mo > 2SD T2p-BB, > 2SD LGE 100% had oedema at d2. AAR stable over 1st week (37% vs 39% LVM). Decreased by 2 wk and nearly resolved at 6 mo Carlsson et al [138] 2009 16 different T2 preparation (TE) times. T2 mapping has shown excellent reproducibility and no effect of slow-flow, throughplane movement, SI loss, or effects of coil SI inhomogeneities [151, 178] . T2 mapping accurately assessed oedema in 96% of patients (good image quality in 100%), whereas T2wSTIR detected oedema in only 67% of patients (15% nondiagnostic 15%) [151] . High observer agreement and close agreement between T1 (r 2 = 0.94) and T2 maps (r 2 = 0.96), and fluorescent microspheres for AAR detection was seen in canine myocardium [179] .
T2* mapping (transverse relaxation in presence of field inhomogeneities)
T2* mapping allows visualisation and quantification of IMH due to the presence of paramagnetic haemoglobin breakdown products. A cutoff value of < 20 ms has been used to define the presence of IMH [180] . Although the evidence base for T2* mapping in assessing IMH is currently limited, O'Regan demonstrated that it has greater sensitivity than T2wSTIR imaging (100% vs 90%) for IMH. Kali showed good correlation between invivo T2* and histological assessment of IMH and iron levels in canine myocardium [127, 128] . T2* mapping may improve the specificity of IMH detected on CMR [131] . T1, T2 and T2* surrogate markers hold promise for improving the accuracy of detection of infarct, oedema and IMH respectively, and further improving statistical power of STEMI studies. However, due to the importance of values obtained [170, 171] . These methods are not reliant on reference regions of interest and do not suffer from T2w TSE artefacts.
T1 mapping (longitudinal relaxation)
T1 relaxation curves allow calculation of the T1 time (time taken for recovery of 63% of longitudinal magnetization). The currently used curvefitting sequences used include MOLLI (Modified LookLocker Inversion Recovery), ShMOLLI (Shortened MOLLI), SASHA (SAturation recovery singleSHot Acquisition) and SAPPHIRE (SAturation Pulse Prepared Heart rate independent Inversion REcovery) [172] .
Infarcted and oedematous myocardium demonstrate prolonged precontrast T1 values and reduced post contrast T1 values compared with normal myocardium, allowing infarct visualisation and quantification [169, 170, 173, 174] . Messroghli showed that this technique had high test retest reproducibility [175] , was stable within the range of heart rates commonly seen in clinical practice and showed comparable sensitivity for IS quantification compared with LGE [169, 173, 176] . T1 values within in the infarct core were recently shown to demonstrate a strong inverse correlation with LMVO extent, incidence of LV remodelling and allcause mortality at 2.5 years [177] .
T2 mapping (transverse relaxation)
T2w images are generated using a T2SSFP sequence with log-transformed curve-fitting T2 quantification, with Masci et al [26] 2010 
Follow-up
Eitel et al [34] 2011 Eitel et al [161] 2010 The high MSI in RVI often > 90% [187, 188] is thought to be due the relatively low RV nutrient needs, direct endocardial oxygen diffusion and good collateral blood supply [188, 189] .
Prognostic importance of CMR-derived right ventricular infarction in AMI
RVI confers adverse shortterm prognosis, with a large metaanalysis (n = 7136) demonstrating that RVI on ECG, echocardiography or radionucleotide imaging predicted 30d mortality and inhospital MACE [190] . Shah demonstrated the prognostic importance of right ventricular infarction on imaging, where RVEF < 38% on radionucleotide ventriculography post STEMI was a strong independent predictor of 1year mortality [191] . Right ventricular infarction is a strong independent predictor of medium to longterm prognosis in a small number of CMR of protocol standardisation, these techniques are rarely used in multicentre studies at present.
RIGHT VENTRICULAR INVOLVEMENT IN AMI
CMR assessment of right ventricular infarction in AMI
CMR is the gold standard imaging modality for the assessment of right ventricular (RV) volumes, function, oedema [181] and infarction (RVI) [182] . CMR identifies RVI with greater sensitivity than echocardiography, ECG (V4R STsegment elevation) and clinical examination [183, 184] and demonstrates RV LMVO [185, 186] . There is good interobserver and intraobserver agreement for the identification of RV oedema (κ = 0.62, κ = 0.62, respectively) and very good agreement for RVI (κ = 0.70, κ = 0.70, respectively) [181] . [33] 2012 304 2SD IS extent IP for LVR in model with LVEF, IS, LV volumes, MVO 6 d 189 d IS Monmeneu et al [91] 2012 118 2SD Number of segments > 50% transmurality IP for LVR 6 d 6 mo IS Wu et al [94] 2008 [177] 2016 300 T1 map, 2SD STIR, 5SD
LGE Indeed the drop in AAR extent on the gold standard of histological water analysis in their study at 2 d was much less pronounced, and at 7 d AAR extent had returned to stable peak levels. In addition, studies demonstrating close agreement between T2wderived AAR and the reference noninvasive modality of SPECT [138, 139] were undertaken at 7 d post STEMI. MVO and IMH extent peak at 48 h then decrease [18] but are present at 7 d [9, 18] . Although undertaking CMR at 7d may potentially underestimate MVO and IMH extent [9, 18, 74] , this may be minimised by expressing MVO and IMH extent as a proportion of IS rather than LV mass, to correct for the corresponding reduction in IS. Thus, acutely post STEMI for the assessment of IS, MSI, MVO and IMH, imaging at 7 d may provide the best compromise in relation to their studies (Table 15) .
WHEN IS THE OPTIMAL TIME TO PERFORM CMR ASSESSMENT IN MI?
In acute STEMI, IS, AAR and MSI are best imaged at 7 d post PPCI due to overestimation of necrosis on LGE, and IS at 7 d best predicts final IS, LV remodelling and function and prognosis [57, 9, 18, 20, 21] . Human studies suggest that AAR is stable during the first week [21, 138] . Although FernándezJiménez et al [165] demonstrated a bimodal AAR peak in pigs, their drop in AAR extent on T2w CMR at 2 d postreperfusion may be due to a high incidence of IMH in pigs and peak IMH extent at 2 d [74] . 
IS
Husser et al [96] 2013 250 > 2SD Extent of transmural infarction was only IP for MACE 7 d 163 wk IS Izquierdo et al [97] 2013 440 > 2SD IS was IP for arrhythmic cardiac events in model including LVEF, hypertension 7 d 123 wk IS Eitel et al [34] 2011 208 > 5SD IS was IP of MACE in model with MVO, LVEF, MSI, Killip, TIMI flow post-PPCI 3 d 18.5 mo IS Larose et al [67] 2010 103 FWHM IS strongest IP for MACE in model with LVEF, CK.
LGE > 23% for MACE 4.5 h 2 yr IS Bodi et al [38] 2009 214 > 2SD Extent of transmural infarction (no. of segments > 50% transmurality) IP for MACE [161] 2010 208 > 2SD/> 5SD MSI only IP for MACE/mortality in model with LVEF, MVO, IS, STR, TIMI post 3 d 6 mo T1 Carrick et al [177] 2016 300 T1 map, > 2SD STIR, > 5SD
Infarct core T1 inverse association with risk of mortality and heart failure hospitalisation, in model with LVEF, infarct T2, IMH. temporal changes [57, 9, 18, 20, 21] for accurate quantification and prediction of LV function, remodelling and prognosis. This needs to be balanced with contemporary clinical practice where patients are typically discharged at 34 d post-PPCI, and the risk of early attrition. Using final IS at followup as a primary outcome risks underestimating potential differences in treatment strategies due to greater infarct resorption with the larger infarcts. Data on the chronology of IS suggests that infarct resorption is essentially complete by 3 mo post MI [9, 18, 20, 74] . However a key objective of followup CMR is to assess LV geometry and remodelling and hence must allow the relatively slower adaptations of ventricular volumes (approximately 12 mo), compared with changes in IS and LVEF to complete. LVEF shows no significant change after 1mo post STEMI. Followup CMR at 3 and 6mo may fail to provide an accurate assessment of LV volumes and remodelling. The evidence base suggests that in order to allow completion of the trio of IS, LVEF and LV volumetric changes, followup CMR should be performed at 12mo post STEMI [5, 7, 18, 20, 21] . When correlating CMR and clinical outcomes, the longer timepoint of 12mo also permits more reliable clinical followup.
Standardisation of LGE, AAR and IMH sequences and quantification methods is equally important in light of newer T1, T2 and T2*mapping sequences and inherent image quality issues associated with T2wTSE.
CONCLUSION
Contrastenhanced CMR offers robust, validated and reproducible surrogate markers, providing an accurate representation of pathophysiology, assessment of myo cardial function and injury, and predictive value for medium to longterm LV function, remodelling and prognosis following PPCI for STEMI. Tables 16 and 17 summarise the key prospective studies illustrating the independent predictive value of CMR markers for LV remodelling (studies where n > 100, followup CMR ≥ 3 mo post PPCI) and prognosis (studies where n > 100, ≥ 6 mo followup) respectively.
In the acute phase, CMR can be performed accurately for up to 7 d post PPCI. CMR delivers no radiation to the patient and this makes it ideal for serial studies. The multimodal nature of CMR allows a multiparametric study of cardiac function, structure and volumes within a single study, which can be undertaken within approximately 45 min in the majority of patients. It is likely that CMR will become the mainstay of cardiac imaging, providing an important role in risk stratification and treatment post STEMI. Focus needs to be continued in translating findings on the prognostic importance of surrogate markers to development of therapeutic targets post STEMI.
